AstraZeneca PLC is 68.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($286.27 B vs $4.18 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DNTH | AZN |
|---|---|---|
| Market cap | $4.18 B | $286.27 B |
| US-listed rank | #1530 | #45 |
| Revenue (latest FY) | $2.04M | - |
| Net income (latest FY) | -$162.34M | - |
| Net margin | -7973.3% | - |
| SEC filings | 624 | 1,004 |
AstraZeneca PLC is 68.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($286.27 B vs $4.18 B).
Full pages: Dianthus Therapeutics, Inc. /DE/ and AstraZeneca PLC, or browse the full rankings.